Routine anaerobic blood cultures: Back where we started?

Clinical Infectious Diseases

Volumn 44, Issue 7, 2007, Pages 901-903

  Hecht, David W ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAEROBIC BACTERIUM; BACTEREMIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BACTEROIDES DISTASONIS; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES VULGATUS; BLOOD CULTURE; CLOSTRIDIUM; CLOSTRIDIUM NOVYI; CLOSTRIDIUM SORDELLII; HUMAN; INFECTION RISK; NONHUMAN; NOTE; PRIORITY JOURNAL; RISK FACTOR;

BACTEREMIA; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; BLOOD; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; MALE; SENSITIVITY AND SPECIFICITY;

EID: 33947379147     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/512440     Document Type: Note

References (25)

1. Morris AJ, Wilson ML, Mirrett S, Reller LB. Rationale for selective use of anaerobic blood cultures. J Clin Microbiol 1993; 31:2110-3.
2. Ortiz E, Sande MA. Routine use of anaerobic blood cultures: are they still indicated? Am J Med 2000; 108:445-7.
3. Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect 2006; 12:527-32.
4. Dorsher CW, Rosenblatt JE, Wilson WR, Ilstrup DM. Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis 1991; 13:633-6.
5. Brook I. Clinical review: bacteremia caused by anaerobic bacteria in children. Crit Care 2002; 6:205-11.
6. Freedman SB, Roosevelt GE. Utility of anaerobic blood cultures in a pediatric emergency department. Pediatr Emerg Care 2004; 20: 433-6.
7. Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE. Reemergence of anaerobic bacteremias. Clin Infect Dis 2007; 44:895-900 (in this issue).
8. Lombardi DP, Engleberg NC. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med 1992; 92: 53-60.
9. Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis 1996; 23(Suppl 1):S97-101.
10. Peraino VA, Cross SA, Goldstein EJ. Incidence and clinical significance of anaerobic bacteremia in a community hospital. Clin Infect Dis 1993; 16(Suppl 4):S288-91.
11. Zahar JR, Farhat H, Chachaty E, Meshaka P, Antoun S, Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin Microbiol Infect 2005; 11:724-9.
12. Snydman DR, Jacobus NV, McDermott LA, et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends for 1997-2000. Clin Infect Dis 2002; 35:S126-34.
13. Snydman DR, McDermott L, Cuchural GJ Jr, et al. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis 1996; 23(Suppl 1): S54-65.
14. Golan Y, McDermott LA, Jacobus NV, et al. Emergence of fluoroquinolone resistance among Bacteroides species. J Antimicrob Chemother 2003; 52:208-13.
15. Nguyen MH, Yu VL, Morris AJ, et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis 2000; 30:870-6.
16. Bieluch VM, Cuchural GJ, Snydman DR, Gorbach SL, Tally FP. Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates. Diagn Microbiol Infect Dis 1987; 7:119-26.
17. Snydman DR, Cuchural GJ Jr, McDermott L, Gill M. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis. Antimicrob Agents Chemother 1992; 36: 540-4.
18. Dalmau D, Cayouette M, Lamothe F, et al. Clindamycin resistance in the Bacteroides fragilis group: association with hospital-acquired infections. Clin Infect Dis 1997; 24:874-7.
19. Salonen JH, Eerola E, Meurman O. Clinical significance and outcome of anaerobic bacteremia. Clin Infect Dis 1998; 26:1413-7.
20. Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A7. 7th ed. Wayne, PA: CLSI, 2007.
21. Khan AA, Davenport K. A reminder of the association between Clostridium septicum and colonic adenocarcinoma. Int Semin Surg Oncol 2006; 3:12.
22. Aldape MJ, Bryant AE, Stevens DL. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006; 43: 1436-46.
23. Murray-Lillibridge K, Barry J, Reagan S, et al. Epidemiological findings and medical, legal, and public health challenges of an investigation of severe soft tissue infections and deaths among injecting drug users: Ireland, 2000. Epidemiol Infect 2006; 134:894-901.
24. Brazier JS, Hall V, Yusuf E, Duerden BI. Fusobacterium necrophorum infections in England and Wales 1990-2000. J Med Microbiol 2002; 51:269-72.
25. Brook I, Frazier EH. Aerobic and anaerobic infection associated with malignancy. Support Care Cancer 1998; 6:125-31.